This article has been updated from a previous version, which incorrectly stated that 7 percent of Qiagen's third-quarter revenue came from Genaco Biomedical, instead of from acquisitions.
 
NEW YORK (GenomeWeb News) — Qiagen today said third-quarter revenues increased 20 percent as R&D spending rose 29 percent and profit increased 10 percent.
 
Total receipts for the three months ended Sept. 30 increased to $117.9 million from $98.6 million year over year, beating its guidance of $116 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.